Change language
English Deutsch
Change currency
€ EUR £ GBP $ USD
Licensed Unlicensed Requires Authentication Published by De Gruyter July 3, 2012

Further insights on the relationship between bilirubin and C-reactive protein

  • Giuseppe Lippi EMAIL logo and Giovanni Targher
From the journal Clinical Chemistry and Laboratory Medicine (CCLM)
https://doi.org/10.1515/cclm-2012-0343
Keywords: atherosclerosis; bilirubin; C-reactive protein; cardiovascular risk
Corresponding author: Prof. Giuseppe Lippi, U.O. Diagnostica Ematochimica, Dipartimento di Patologia e Medicina di Laboratorio, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126 Parma, Italy Phone: +39 0521 703050, Fax: +39 0521 703056

References

1. Hwang HJ, Lee SW, Kim SH. Relationship between bilirubin and C-reactive protein. Clin Chem Lab Med 2011;49:1823–8.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000296772300008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed

2. Lippi G, Targher G, Montagnana M, Salvagno GL, Guidi GC. Bilirubin concentration and cardiovascular risk profile. Liver Int 2009;29:315–6.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000262284100030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1111/j.1478-3231.2008.01821.xSearch in Google Scholar PubMed

3. Franchini M, Targher G, Lippi G. Serum bilirubin levels and cardiovascular disease risk: a Janus Bifrons? Adv Clin Chem 2010;50:47–63.10.1016/S0065-2423(10)50003-9http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000278107100003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar

4. Lippi G, Favaloro EJ, Montagnana M, Franchini M. C-reactive protein and venous thromboembolism: causal or casual association? Clin Chem Lab Med 2010;48:1693–701.10.1515/CCLM.2010.335Search in Google Scholar PubMed

Received: 2012-06-01
Accepted: 2012-06-12
Published Online: 2012-07-03
Published in Print: 2012-12-01

©2012 by Walter de Gruyter Berlin Boston

From the journal
Clinical Chemistry and Laboratory Medicine (CCLM)
Clinical Chemistry and Laboratory Medicine (CCLM)
Volume 50 Issue 12
Submit manuscript

Journal and Issue

Articles in the same Issue

Masthead
Masthead
Editorials
Phlebotomy, stat testing and laboratory organization: an intriguing relationship
Human epididymis protein 4: the start of a post-ROMAn era?
Hyperhomocysteinemia in health and disease: where we are now, and where do we go from here?
Reviews
The usefulness of cystatin C and related formulae in pediatrics
The emerging role of biomarkers and bio-impedance in evaluating hydration status in patients with acute heart failure
Biomarkers in primary open angle glaucoma
Mini Review
Identification of circulating microRNAs as biomarkers in cancers: what have we got?
Opinion Paper
HE4 in gynecological cancers: report of a European investigators and experts meeting
Guidelines and Recommendations
Position paper on laboratory testing for patients taking new oral anticoagulants. Consensus document of FCSA, SIMeL, SIBioC and CISMEL1)
General Clinical Chemistry and Laboratory Medicine
Reducing the number of clinical stat phlebotomy orders: feasible or not?
Calculating acid-base and oxygenation status during COPD exacerbation using mathematically arterialised venous blood
UrineCART, a machine learning method for establishment of review rules based on UF-1000i flow cytometry and dipstick or reflectance photometer
Reference Values and Biological Variations
Assessing seasonality in clinical research
Cancer Diagnostics
Identification of a novel in-frame deletion in BRCA2 and analysis of variants of BRCA1/2 in Italian patients affected with hereditary breast and ovarian cancer
Human epididymis protein 4 (HE4) in benign and malignant diseases
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome
A predictive equation to adjust for clinical variables in soluble mesothelin-related protein (SMRP) levels
Cardiovascular Diseases
Vitamin D deficiency parallels inflammation and immune activation, the Ludwigshafen Risk and Cardiovascular Health (LURIC) study
Plasma homocysteine and the risk of venous thromboembolism: insights from the FIELD study
Letters to the Editor
A two-base-pairs deletion in the albumin gene causes a new case of analbuminemia
Usefulness of an antiglycolytic granular mixture of sodium fluoride and citrate for stabilizing plasma homocysteine levels
Further insights on the relationship between bilirubin and C-reactive protein
Phosphoethanolamine normal range in pediatric urines for hypophosphatasia screening
Risk of false positive hepatitis C virus RNA due to sample to sample carryover on an automated hematology analyzer
Lack of commutability between a quality control material and plasma samples in a troponin I measurement system
Biological variation in pregnancy-associated plasma protein-A in healthy men and non-pregnant healthy women
Investigation of a slope discontinuity in a patients’ results distribution for D-dimer
Acknowledgment
Acknowledgment
Downloaded on 28.4.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2012-0343/html
Scroll to top button